Rosemarie Loffredo
Director of Finance/CFO at The Leukemia & Lymphoma Society, Inc.
Profile
Rosemarie Loffredo is currently the Chief Financial & Administrative Officer at The Leukemia & Lymphoma Society, Inc. She holds an MBA from The Trustees of Columbia University in The City of New York, a graduate degree from Boston College, and an undergraduate degree from Georgetown University.
Rosemarie Loffredo active positions
| Companies | Position | Start |
|---|---|---|
The Leukemia & Lymphoma Society, Inc.
 The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY. | Director of Finance/CFO | 23/07/2013 |
Training of Rosemarie Loffredo
| Georgetown University | Undergraduate Degree |
| Boston College | Graduate Degree |
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
The Leukemia & Lymphoma Society, Inc.
The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY. | Commercial Services |
- Stock Market
- Insiders
- Rosemarie Loffredo
